CYP1A1 and breast cancer: The PAIB-SOs have been shown to display potent cytotoxic activity in both CYP1A1-expressing hormone-dependent and chemo-resistant breast cancers cells both in vitro and in vivo via N-dealkylation and prodrug activation (Figure 3) [49].